Active fragments obtained by cyanogen bromide cleavage of ovomucoid.
Cleavage of the two methionine residues in the glycoprotein trypsin inhibitor ovomucoid, variant O1, with CNBr resulted in two fragments whose mol.wts. were approx. 16 600 (fragment LS) and 11 000 (fragment M). Both fragments formed precipitates with antisera to ovomucoid. Fragment LS retained 56% of the trypsin-inhibitory activity of ovomucoid, but fragment M did not inhibit. After reduction and alkylation, the molecular weight of fragment M was unchanged, but fragment LS could be resolved into two segments of peptide chain with mol.wts. of approx. 12000 (fragment L) and 4700 (fragment S). Each of these peptides contained carbohydrate. Marked heterogeneity was observed in the hexose and hexosamine contents of fragment L. This may account for much of the heterogeneity in neutral carbohydrate occurring in ovomucoid preparations. It was found that fragment M was located at the N-terminal end, fragment S was in the centre and fragment L made up the C-terminal portion of the molecule.
D000596:Amino Acids / Q000032:analysis; D002241:Carbohydrates / Q000032:analysis; D003488:Cyanogen Bromide; D004527:Egg Proteins / Q000032:analysis*; D006595:Hexosamines / Q000032:analysis; D006601:Hexoses / Q000032:analysis; D008970:Molecular Weight; D010059:Ovomucin / Q000032:analysis* / Q000494:pharmacology; D010446:Peptide Fragments / Q000032:analysis / Q000276:immunology; D014361:Trypsin Inhibitors
D000596:Amino Acids; D002241:Carbohydrates; D004527:Egg Proteins; D006595:Hexosamines; D006601:Hexoses; D010446:Peptide Fragments; D014361:Trypsin Inhibitors; D010059:Ovomucin; D003488:Cyanogen Bromide